Skip to main content

Advertisement

Table 3 Previous and current treatment (nonNPSLE/NPSLE patients)

From: Altered white matter microstructure in lupus patients: a diffusion tensor imaging study

  NonNPSLE patients (n = 25) NPSLE patients (n = 39) Fischer’s exact test
Previous treatment
 Glucocorticoids 23 34 0.278
 Antimalarials 26 36 0.219
 DMARDs 20 32 0.249
Current treatment
 Glucocorticoids 19 31 0.487
 Antimalarials 21 28 0.207
 DMARDs 16 23 0.446
 Cyclophosphamide 1 0 0.391
 MMF 4 11 0.207
 Azathioprin 10 10 0.175
 Rituximab 0 1 0.609
 IVIG 1 1 0.632
 Methotrexate 0 1 0.609
 Thalidomide
 Leukeran
 Belimimab 6 2 0.0034
 Antihypertensive treatment 7 13 0.435
 SSRI/SNRI 0 2 0.368
  1. There were no significant differences in previous or current treatment strategies between the groups, with the exception of current treatment of belimimab that was more frequent in the nonNPSLE subgroup
  2. NPSLE neuropsychiatric systemic lupus erythematosus, DMARD disease-modifying antirheumatic drug, MMF mycophenolate mofetil, IVIG intravenous immunoglobulins, SSRI/SNRI serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors